CWR22: Androgen-dependent Xenograft Model Derived from a Primary Human Prostatic Carcinoma

Mark A. Wainstein, Feng He, Robinson D, Hsing-Jien Kung, Stuart Schwartz, Joseph M. Giaconia, Nancy L. Edgehouse, Theresa P. Pretlow, Donald R. Bodner, Elroy D. Kursh, Martin I. Resnick, Allen Seftel, Thomas G. Pretlow

研究成果: 雜誌貢獻文章同行評審

210 引文 斯高帕斯(Scopus)


The long-term propagation of primary human prostate cancer (PCA) in vivo or in vitro has been rare. Most such PC As are phenotypically different from most PCAs in humans; i.e., they make little prostate specific antigen and respond little, if at all, to androgen deprivation. A serially transplantable, primary human PCA, designated CWR22, exhibits a clonal cytogenetic aberration, causes high elevations of prostate specific antigen in the peripheral blood of nude mice, and is unusually responsive to androgen deprivation as compared with other xenografts. Studies of mRNA from CWR22 have demonstrated the expression of prostate specific antigen and the epidermal growth factor receptor family including erbB1/epidermal growth factor receptor, erbB2/neu, and erbB3, but not erbB4. A ligand for these receptors, the neu differentiation factor, is also expressed.
頁(從 - 到)6049-6052
期刊Cancer Research
出版狀態已發佈 - 1月 1 1994

ASJC Scopus subject areas

  • 腫瘤科
  • 癌症研究


深入研究「CWR22: Androgen-dependent Xenograft Model Derived from a Primary Human Prostatic Carcinoma」主題。共同形成了獨特的指紋。